Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes (Q46108373)

From Wikidata

Jump to navigation Jump to search

scientific article published on 4 December 2008

Language	Label	Description	Also known as
English	Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes	scientific article published on 4 December 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

1 reference

based on heuristic

inferred from title

object named as

Xin M Luo

1

0 references

David Baltimore

6

object named as

David Baltimore

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

author name string

Emily Maarschalk

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

Ryan M O'Connell

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

Pin Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

Lili Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

language of work or name

0 references

publication date

4 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

113

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

1422-1431

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

Production of high-titer helper-free retroviruses by transient transfection

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1073/PNAS.90.18.8392

Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Myeloid lineage commitment from the hematopoietic stem cell

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Antibody vs. HIV in a clash of evolutionary titans

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Immunotherapeutic potential of bispecific antibodies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Progress and obstacles in the development of an AIDS vaccine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

The rational design of an AIDS vaccine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

A quantitative assay for HIV DNA integration in vivo

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Assessment and characterization of hemopoietic stem cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Gene rearrangement and B-cell development

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

GP120: target for neutralizing HIV-1 antibodies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Understanding and making use of human memory B cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Engineered antibody Fc variants with enhanced effector function

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Comparing antigenicity and immunogenicity of engineered gp120.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

CD38 low IgG-secreting cells are precursors of various CD38 high-expressing plasma cell populations

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Culture system for extensive production of CD19+IgM+ cells by human cord blood CD34+ progenitors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1182/BLOOD-2008-09-177139

Identifiers

10.1182/BLOOD-2008-09-177139

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19059876

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46108373&oldid=2093201671"